SCHEMBL13009972

SCHEMBL13009972

CCOCOC1C(O)C(COC)OC1n1cnc2c(N)ncnc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 6/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ DNPH1 O43598 1/20 0.54
▸ PRKAB2 O43741 1/20 0.54
▸ TRPM2 O94759 1/20 0.54
▸ LDHA P00338 1/20 0.54
▸ ADRB2 P07550 1/20 0.54
▸ FBP1 P09467 1/20 0.54
▸ SRC P12931 1/20 0.54
▸ P2RY2 P41231 1/20 0.54
▸ P2RY1 P47900 1/20 0.54
▸ PRKAG1 P54619 1/20 0.54
▸ PRKAA2 P54646 1/20 0.54
▸ PDE4D Q08499 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ PRKAA1 Q13131 1/20 0.54
▸ PDE3A Q14432 1/20 0.54
▸ TAS1R3 Q7RTX0 1/20 0.54
▸ TAS1R1 Q7RTX1 1/20 0.54
▸ P2RY11 Q96G91 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13009973 0.93 ADORA1 (0.56) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL13010014 0.89 AHCY (0.53) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL21999787 0.88 ADORA1 (0.61) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL8626012 0.87 ADORA3 (0.64) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL21999233 0.87 ADORA3 (0.64) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL12360837 0.87 ADORA3 (0.64) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL12376383 0.87 ADORA3 (0.64) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL13009986 0.86 ADORA1 (0.60) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL22535909 0.86 GAA (0.50) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2
SCHEMBL21999229 0.85 AHCY (0.56) ADORA1SMN1; SMN2DNPH1PRKAB2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317714-A1 COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS SUZHOU RIBO LIFE SCIENCE CO., LTD (CN) 2010-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317714-A1 COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS DCLRE1B, RNASE1, AGO2 ADORA1 3979/4885SMN1; SMN2 1142/4885DNPH1 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback